Myriad Genetics Inc (MYGN): Shares Outstanding
93.50M
As of 2025-12-31
95.60M
As of 2026-06-30
+4.8%
3-year compound annual growth
+4.4%
5-year compound annual growth
| Period ended | Shares Outstanding | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | 93.50M | +2.4% | 2026-02-24, Balance as of period end |
| 2024-12-31 | 91.30M | +1.6% | 2026-02-24, Balance as of period end |
| 2023-12-31 | 89.90M | +10.7% | 2026-02-24, Balance as of period end |
| 2022-12-31 | 81.20M | +1.5% | 2025-02-28, Balance as of period end |
| 2021-12-31 | 80.00M | +6.1% | 2024-02-28, Balance as of period end |
| 2020-12-31 | 75.40M | n/a | 2023-03-01, Balance as of period end |
| 2020-06-30 | 74.70M | +1.6% | 2023-03-01, Balance as of period end |
| 2019-06-30 | 73.50M | +4.1% | 2022-02-25, Balance as of period end |
| 2018-06-30 | 70.60M | +3.2% | 2020-08-13, Balance as of period end |
| 2017-06-30 | 68.40M | -1.0% | 2019-08-13, Balance as of period end |
| 2016-06-30 | 69.10M | +0.3% | 2018-08-24, Balance as of period end |
| 2015-06-30 | 68.90M | -6.3% | 2018-08-24, Balance as of period end |
| 2014-06-30 | 73.50M | -8.8% | 2016-08-10, Balance as of period end |
| 2013-06-30 | 80.60M | -2.4% | 2015-08-12, Balance as of period end |
| 2012-06-30 | 82.57M | -4.3% | 2013-08-14, Balance as of period end |
| 2011-06-30 | 86.24M | -8.3% | 2012-08-15, Balance as of period end |
| 2010-06-30 | 94.05M | n/a | 2011-08-15, Balance as of period end |